These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8209893)

  • 1. Population screening for carrier status: effects of test limitations on precision of carrier prevalence rates.
    Parker RA; Phillips JA
    Am J Med Genet; 1994 Feb; 49(3):317-22. PubMed ID: 8209893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of CFTR mutations in an isolated population: identification of carriers and patients.
    Chiba-Falek O; Nissim-Rafinia M; Argaman Z; Genem A; Moran I; Kerem E; Kerem B
    Eur J Hum Genet; 1998; 6(2):181-4. PubMed ID: 9781064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier risk calculations for recessive diseases when not all the mutant alleles are detectable.
    Curnow RN
    Am J Med Genet; 1994 Aug; 52(1):108-14. PubMed ID: 7977452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The views of general practitioners on community carrier screening for cystic fibrosis.
    Boulton M; Cummings C; Williamson R
    Br J Gen Pract; 1996 May; 46(406):299-301. PubMed ID: 8762747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of family history on disclosure patterns of cystic fibrosis carrier status.
    Ormond KE; Mills PL; Lester LA; Ross LF
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):70-7. PubMed ID: 12704640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis carrier frequencies in populations of African origin.
    Padoa C; Goldman A; Jenkins T; Ramsay M
    J Med Genet; 1999 Jan; 36(1):41-4. PubMed ID: 9950364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A universal array-based multiplexed test for cystic fibrosis carrier screening.
    Amos JA; Bridge-Cook P; Ponek V; Jarvis MR
    Expert Rev Mol Diagn; 2006 Jan; 6(1):15-22. PubMed ID: 16359263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina.
    Roqué M; Godoy CP; Castellanos M; Pusiol E; Mayorga LS
    Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
    Farrell PM; Koscik RE
    Pediatrics; 1996 Apr; 97(4):524-8. PubMed ID: 8632940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward genetic carrier screening for cystic fibrosis among pregnant women: the role of health beliefs and avoidant coping style.
    Fang CY; Dunkel-Schetter C; Tatsugawa ZH; Fox MA; Bass HN; Crandall BF; Grody WW
    Womens Health; 1997; 3(1):31-51. PubMed ID: 9106369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST).
    Morgenthaler S; Thilly WG
    Mutat Res; 2007 Feb; 615(1-2):28-56. PubMed ID: 17101154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medico-genetic study of the population of Uzbekistan. VIII. Territorial distribution of hereditary diseases in the population of four regions of the Khorezm province and its genetic load].
    Ginter EK; Budagova KA; Revazov AA; Krasnopol'skaia KD; Dadali EL
    Genetika; 1986 Mar; 22(3):519-26. PubMed ID: 2937688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on population-based preconception and prenatal cystic fibrosis carrier screening.
    Nolen AA; Rhoades ED
    J Okla State Med Assoc; 2003 Oct; 96(10):482-4. PubMed ID: 14619603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services.
    Henneman L; Bramsen I; van Kempen L; van Acker MB; Pals G; van der Horst HE; Adèr HJ; van der Ploeg HM; ten Kate LP
    Community Genet; 2003; 6(1):5-13. PubMed ID: 12748433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One founder/one gene hypothesis in a new expanding population: Saguenay (Quebec, Canada).
    Heyer E
    Hum Biol; 1999 Feb; 71(1):99-109. PubMed ID: 9972101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
    Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
    J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome.
    Battaile KP; Battaile BC; Merkens LS; Maslen CL; Steiner RD
    Mol Genet Metab; 2001 Jan; 72(1):67-71. PubMed ID: 11161831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.